Sussex Research Laboratories Inc.

Profile

Sussex Research Laboratories Inc. (Ottawa, Canada) is a globally recognized specialist in empowering therapeutic innovation through glycoscience. With 30 years of experience as a contract research and development (CRO) partner, Sussex Research collaborates with pharmaceutical, biotechnology, and life science organizations worldwide. Its expertise spans glycodesign, glycan and glycoconjugate synthesis, and advanced linker chemistries, with applications in vaccines, protein and antibody engineering, targeted drug delivery, and emerging therapeutic modalities. It supports the development of oligonucleotide, peptide, protein, lipid, and small-molecule therapeutics, as well as lipid nanoparticle (LNP) technologies. Sussex Research also offers a portfolio of 1,000+ advanced glycan, glycopeptide, glycoconjugate, and targeting ligand/linker products for drug discovery and development.

With deep scientific expertise and worldwide recognition supporting leading biopharmaceutical organizations, Sussex Research aims to be a strategic technology partner for organizations advancing innovative medicines and targeted drug delivery technologies through glycoscience and glycotechnology.

Website

sussex-research.com

Contact


Event details

Date: October 7 - 9, 2026

Event contact

Stephen Ip
Senior International Market Consultant
Japan and Korea

Participants

13 in total